Letrozole is an aromatase inhibitor used as an adjuvant treatment for hormone-dependent breast cancer. It inhibits peripheral estrogen production in fat tissues, where it prevents the conversion of testosterone into estradiol. It has similar safety and efficacy to anastrozole.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.